Immunohistochemistry

Nahal Boroumand

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Immunohistochemistry is important for both distinguishing benign mesothelial proliferations from diffuse malignant mesothelioma (DMM) and for differentiating DMM from metastatic malignancies involving the pleura. Histologic diagnosis alone is often impossible. The exact makeup of immunohistochemical panels used for DMM diagnosis depends on the differential diagnosis and on the antibodies available in a given laboratory. Distinguishing reactive mesothelial cell hyperplasia from DMM is a significant challenge for which the role of immunohistochemistry is limited; however, it is extremely helpful when examining tissue for invasion to the stroma, fat, or lung parenchyma. The role of immunohistochemistry is also relatively limited in sarcomatous DMM diagnosis because mesothelial markers are less often positive.

Original languageEnglish (US)
Title of host publicationDiffuse Malignant Mesothelioma
PublisherSpringer New York
Pages93-105
Number of pages13
ISBN (Print)9781493923748, 9781493923731
DOIs
StatePublished - Jan 1 2015

Fingerprint

Immunohistochemistry
Pleura
Fats
Hyperplasia
Tissue
Differential Diagnosis
Malignant Mesothelioma
Antibodies
Lung
Neoplasms

Keywords

  • Calretinin
  • Immunohistochemistry
  • Keratin
  • Mesothelioma
  • Thrombomodulin
  • WT1

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Boroumand, N. (2015). Immunohistochemistry. In Diffuse Malignant Mesothelioma (pp. 93-105). Springer New York. https://doi.org/10.1007/978-1-4939-2374-8_5

Immunohistochemistry. / Boroumand, Nahal.

Diffuse Malignant Mesothelioma. Springer New York, 2015. p. 93-105.

Research output: Chapter in Book/Report/Conference proceedingChapter

Boroumand, N 2015, Immunohistochemistry. in Diffuse Malignant Mesothelioma. Springer New York, pp. 93-105. https://doi.org/10.1007/978-1-4939-2374-8_5
Boroumand N. Immunohistochemistry. In Diffuse Malignant Mesothelioma. Springer New York. 2015. p. 93-105 https://doi.org/10.1007/978-1-4939-2374-8_5
Boroumand, Nahal. / Immunohistochemistry. Diffuse Malignant Mesothelioma. Springer New York, 2015. pp. 93-105
@inbook{a92a1a5aec914424b0d49f822e60625e,
title = "Immunohistochemistry",
abstract = "Immunohistochemistry is important for both distinguishing benign mesothelial proliferations from diffuse malignant mesothelioma (DMM) and for differentiating DMM from metastatic malignancies involving the pleura. Histologic diagnosis alone is often impossible. The exact makeup of immunohistochemical panels used for DMM diagnosis depends on the differential diagnosis and on the antibodies available in a given laboratory. Distinguishing reactive mesothelial cell hyperplasia from DMM is a significant challenge for which the role of immunohistochemistry is limited; however, it is extremely helpful when examining tissue for invasion to the stroma, fat, or lung parenchyma. The role of immunohistochemistry is also relatively limited in sarcomatous DMM diagnosis because mesothelial markers are less often positive.",
keywords = "Calretinin, Immunohistochemistry, Keratin, Mesothelioma, Thrombomodulin, WT1",
author = "Nahal Boroumand",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-2374-8_5",
language = "English (US)",
isbn = "9781493923748",
pages = "93--105",
booktitle = "Diffuse Malignant Mesothelioma",
publisher = "Springer New York",

}

TY - CHAP

T1 - Immunohistochemistry

AU - Boroumand, Nahal

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Immunohistochemistry is important for both distinguishing benign mesothelial proliferations from diffuse malignant mesothelioma (DMM) and for differentiating DMM from metastatic malignancies involving the pleura. Histologic diagnosis alone is often impossible. The exact makeup of immunohistochemical panels used for DMM diagnosis depends on the differential diagnosis and on the antibodies available in a given laboratory. Distinguishing reactive mesothelial cell hyperplasia from DMM is a significant challenge for which the role of immunohistochemistry is limited; however, it is extremely helpful when examining tissue for invasion to the stroma, fat, or lung parenchyma. The role of immunohistochemistry is also relatively limited in sarcomatous DMM diagnosis because mesothelial markers are less often positive.

AB - Immunohistochemistry is important for both distinguishing benign mesothelial proliferations from diffuse malignant mesothelioma (DMM) and for differentiating DMM from metastatic malignancies involving the pleura. Histologic diagnosis alone is often impossible. The exact makeup of immunohistochemical panels used for DMM diagnosis depends on the differential diagnosis and on the antibodies available in a given laboratory. Distinguishing reactive mesothelial cell hyperplasia from DMM is a significant challenge for which the role of immunohistochemistry is limited; however, it is extremely helpful when examining tissue for invasion to the stroma, fat, or lung parenchyma. The role of immunohistochemistry is also relatively limited in sarcomatous DMM diagnosis because mesothelial markers are less often positive.

KW - Calretinin

KW - Immunohistochemistry

KW - Keratin

KW - Mesothelioma

KW - Thrombomodulin

KW - WT1

UR - http://www.scopus.com/inward/record.url?scp=84944590261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944590261&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-2374-8_5

DO - 10.1007/978-1-4939-2374-8_5

M3 - Chapter

AN - SCOPUS:84944590261

SN - 9781493923748

SN - 9781493923731

SP - 93

EP - 105

BT - Diffuse Malignant Mesothelioma

PB - Springer New York

ER -